Xiaoyuan Wang Selected Research

Therapeutics

10/2023	3D printing to construct in vitro multicellular models of melanoma.
1/2023	Protection against Doxorubicin-Induced Cardiotoxicity by Ergothioneine.
4/2022	Association between T-tau protein and Aβ42 in plasma neuronal-derived exosomes and cognitive impairment in patients with permanent atrial fibrillation and the role of anticoagulant therapy and inflammatory mechanisms.
1/2022	Nucleus-Targeting Phototherapy Nanodrugs for High-Effective Anti-Cancer Treatment.
1/2022	Mitochondria-Targeting Chemodynamic Therapy Nanodrugs for Cancer Treatment.
1/2022	Clinical Comparison of Endoscopic Ultrasonography and CT in Preoperative TN Staging of Esophagogastric Junction Cancer.
9/2021	Epigenetic derepression converts PPARγ into a druggable target in triple-negative and endocrine-resistant breast cancers.
11/2018	Hierarchically Self-Assembled Supramolecular Host-Guest Delivery System for Drug Resistant Cancer Therapy.
2/2018	Overcoming STC2 mediated drug resistance through drug and gene co-delivery by PHB-PDMAEMA cationic polyester in liver cancer cells.
1/2018	Thermoresponsive Supramolecular Chemotherapy by "V"-Shaped Armed β-Cyclodextrin Star Polymer to Overcome Drug Resistance.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xiaoyuan Wang Research Topics

Disease

37	Neoplasms (Cancer) 04/2024 - 01/2013
11	Infections 05/2024 - 09/2011
7	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2023 - 03/2014
5	Neoplasm Metastasis (Metastasis) 03/2024 - 12/2015
5	Breast Neoplasms (Breast Cancer) 10/2023 - 07/2017
5	Myocardial Infarction 01/2022 - 01/2017
4	Lung Neoplasms (Lung Cancer) 03/2024 - 05/2016
4	Esophageal Squamous Cell Carcinoma 12/2023 - 11/2021
4	Inflammation (Inflammations) 01/2023 - 01/2021
3	Hypertension (High Blood Pressure) 03/2022 - 10/2018
3	Disease Progression 01/2022 - 05/2016
3	Stomach Neoplasms (Stomach Cancer) 01/2022 - 11/2018
3	Hereditary Nephritis (Alport Syndrome) 11/2021 - 01/2020
3	Carcinoma (Carcinomatosis) 11/2021 - 07/2014
3	Sepsis (Septicemia) 05/2021 - 01/2010
3	Septic Shock (Toxic Shock Syndrome) 05/2021 - 05/2014
3	Fibrosis (Cirrhosis) 02/2021 - 01/2017
3	Infarction (Infarctions) 01/2021 - 01/2019
2	Thalassemia 05/2024 - 01/2022
2	Starvation 12/2023 - 12/2021
2	Conversion Disorder (Astasia Abasia) 04/2023 - 04/2023
2	Neuromyelitis Optica (Devic's Disease) 02/2023 - 10/2021
2	Weight Gain 01/2023 - 10/2022
2	Atherosclerosis 01/2023 - 03/2021
2	Non-alcoholic Fatty Liver Disease 01/2023 - 03/2021
2	Atherosclerotic Plaque (Atheroma) 01/2023 - 03/2021
2	Cognitive Dysfunction 04/2022 - 02/2022
2	Thymoma (Thymic Carcinoma) 01/2022 - 02/2021
2	Coronary Disease (Coronary Heart Disease) 01/2022 - 01/2019
2	Hypoxia (Hypoxemia) 03/2021 - 01/2021
2	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 03/2021 - 05/2014
2	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 01/2021
2	Renal Cell Carcinoma (Grawitz Tumor) 06/2020 - 10/2018
1	Lupus Nephritis 05/2024
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 05/2024
1	Insulin Resistance 02/2024
1	Chronic Pancreatitis 02/2024
1	Diabetes Mellitus 02/2024
1	Pancreatitis 02/2024
1	Diarrhea 01/2024
1	Ulcerative Colitis 01/2024
1	Colitis 01/2024
1	Bacteremia 12/2023
1	Meningitis 12/2023

Drug/Important Bio-Agent (IBA)

11	Proteins (Proteins, Gene)FDA Link 01/2024 - 05/2016
9	Biomarkers (Surrogate Marker)IBA 05/2024 - 03/2014
8	MicroRNAs (MicroRNA)IBA 01/2024 - 12/2015
5	Paclitaxel (Taxol)FDA LinkGeneric 12/2023 - 07/2014
5	Messenger RNA (mRNA)IBA 11/2021 - 01/2017
4	CytokinesIBA 01/2024 - 11/2016
4	LipidsIBA 12/2023 - 03/2021
4	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2023 - 01/2022
4	AntioxidantsIBA 01/2023 - 12/2015
4	Long Noncoding RNAIBA 01/2023 - 10/2018
3	RNA (Ribonucleic Acid)IBA 03/2024 - 11/2021
3	Cisplatin (Platino)FDA LinkGeneric 10/2023 - 12/2015
3	CollagenIBA 01/2023 - 01/2017
3	Lipid AIBA 10/2016 - 12/2004
2	Insulin (Novolin)FDA Link 02/2024 - 01/2022
2	Phosphotransferases (Kinase)IBA 12/2023 - 10/2023
2	Fatty Acids (Saturated Fatty Acids)IBA 12/2023 - 01/2018
2	Immune Checkpoint InhibitorsIBA 12/2023 - 06/2023
2	Matrix Metalloproteinase 9 (Gelatinase B)IBA 10/2023 - 01/2012
2	Formaldehyde (Formol)FDA Link 06/2023 - 04/2023
2	CarbonIBA 04/2023 - 04/2023
2	Pyruvaldehyde (Methylglyoxal)IBA 04/2023 - 04/2023
2	Glyoxal (Ethanedial)IBA 04/2023 - 04/2023
2	2,3,5-trimethylpyrazineIBA 04/2023 - 04/2023
2	Transforming Growth Factor-beta Type I ReceptorIBA 03/2023 - 01/2023
2	Rituximab (Mabthera)FDA Link 02/2023 - 10/2021
2	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2023 - 01/2018
2	Liposomes (Liposome)IBA 01/2023 - 10/2017
2	Mycophenolic Acid (Cellcept)FDA LinkGeneric 12/2022 - 10/2021
2	Thromboplastin (Tissue Factor)IBA 01/2022 - 01/2021
2	Circular RNAIBA 01/2022 - 01/2022
2	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 02/2018
2	Therapeutic UsesIBA 01/2022 - 11/2018
2	Staphylococcal Protein A (Protein A)IBA 01/2022 - 12/2021
2	Laminin (Merosin)IBA 05/2020 - 01/2019
2	Competitive Endogenous RNAIBA 10/2019 - 10/2018
2	Tissue Inhibitor of Metalloproteinase-1IBA 10/2019 - 01/2012
2	Ethylene Glycol (Monoethylene Glycol)IBA 11/2018 - 01/2018
2	poly-N-isopropylacrylamideIBA 11/2018 - 01/2018
2	poly(2-(dimethylamino)ethyl methacrylate)IBA 02/2018 - 11/2017
2	Tyrosine Kinase InhibitorsIBA 01/2018 - 03/2014
2	ErbB Receptors (EGF Receptor)IBA 01/2018 - 03/2014
2	Toll-Like Receptor 2IBA 01/2017 - 03/2012
2	EndotoxinsIBA 01/2010 - 06/2008
1	GlobinsIBA 05/2024
1	VaccinesIBA 05/2024
1	Uric Acid (Urate)IBA 05/2024
1	HomocysteineIBA 05/2024
1	Photosensitizing Agents (Photosensitizers)IBA 04/2024
1	Hormones (Hormone)IBA 02/2024

Therapy/Procedure

12	Therapeutics 10/2023 - 05/2016
5	Drug Therapy (Chemotherapy) 12/2023 - 01/2018
2	Neoadjuvant Therapy 01/2022 - 11/2021
2	Chemoradiotherapy 11/2021 - 11/2018
2	Artificial Respiration (Mechanical Ventilation) 03/2021 - 05/2014
2	Radiotherapy 01/2018 - 07/2017